Your Article Summary
(Click the title below to leave the MDLinx Network and go to the Journal's Website)
Erlotinib Warning
JAMA, 06/29/09
Kuehn BM - The US Food and Drug Administration is alerting physicians to new safety warnings on the label of erlotinib, a drug approved for the treatment of certain patients with lung or pancreatic cancer, that warn of reports of serious gastrointestinal tract, skin, and ocular disorders in patients taking the drug.
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
Dell Tries to Make an EHR Splash
HealthDataManagement, 11/03/09
Novel agent for treatment of Parkinson's disease - Lu 02-750 - enters Lundbeck's development pipeline
Lundbeck, 11/02/09
Abbott Statement on ARBITER 6 - HALTS Results and Abbotts Niaspan
Abbott, 11/16/09
Article Search
Sponsor


See Latest Articles


